Shoshana Levy Department of Medicine, Division of Oncology, Stanford University, USA
2 protocols

Minu Srivastava Department of Medicine, Division of Oncology, Stanford University, USA
1 protocol

Felipe Vences-Catalán
  • Research scientist, Department of Medicine, Division of Oncology, Stanford University, USA
Research focus
  • Immunology
  • 2 Author merit
Lab Protocol Hub


Ph.D. in Molecular Biomedicine. Center for Research and Advance Studies of the National Polytechnic Institute (CINVESTAV), Department of Molecular Biomedicine. Mexico City

Current position

Postdoctoral fellow, Department of Medicine, Division of oncology, Stanford University.


  1. Vences-Catalan, F., Rajapaksa, R., Srivastava, M. K., Marabelle, A., Kuo, C. C., Levy, R. and Levy, S. (2015). Tetraspanin CD81, a modulator of immune suppression in cáncer and metástasis. OncoImmunology.

  2. Vences-Catalan, F., Rajapaksa, R., Srivastava, M. K., Marabelle, A., Kuo, C. C., Levy, R. and Levy, S. (2015). Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cells. Cancer Res 75(21): 4517-4526.

  3. Vences-Catalan, F., Kuo, C. C. and Levy, S. (2015). Role of an arginine-lysine rich motif in maturation and trafficking of CD19. Biochem Biophys Res Commun 465(3): 319-323.

  4. Vences-Catalan, F., Kuo, C. C., Sagi, Y., Chen, H., Kela-Madar, N., van Zelm, M. C., van Dongen, J. J. and Levy, S. (2015). A mutation in the human tetraspanin CD81 gene is expressed as a truncated protein but does not enable CD19 maturation and cell surface expression. J Clin Immunol 35(3): 254-263.

  5. Al Olaby, R. R., Cocquerel, L., Zemla, A., Saas, L., Dubuisson, J., Vielmetter, J., Marcotrigiano, J., Khan, A. G., Vences Catalan, F., Perryman, A. L., Freundlich, J. S., Forli, S., Levy, S., Balhorn, R. and Azzazy, H. M. (2014). Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein. PLoS One 9(10): e111333.

  6. Luu, V. P., Hevezi, P., Vences-Catalan, F., Maravillas-Montero, J. L., White, C. A., Casali, P., Llorente, L., Jakez-Ocampo, J., Lima, G., Vilches-Cisneros, N., Flores-Gutierrez, J. P., Santos-Argumedo, L. and Zlotnik, A. (2013). TSPAN33 is a novel marker of activated and malignant B cells. Clin Immunol 149(3): 388-399.

  7. Vences-Catalan, F., Rajapaksa, R., Levy, S. and Santos-Argumedo, L. (2012). The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytes. Immunology 137(1): 48-55.

  8. Vargas-Hernandez, A., Lopez-Herrera, G., Maravillas-Montero, J. L., Vences-Catalan, F., Mogica-Martinez, D., Rojo-Dominguez, A., Espinosa-Rosales, F. J. and Santos-Argumedo, L. (2012). Consequences of two naturally occurring missense mutations in the structure and function of Bruton agammaglobulinemia tyrosine kinase. IUBMB Life 64(4): 346-353.

  9. Vences-Catalan, F. and Santos-Argumedo, L. (2011). CD38 through the life of a murine B lymphocyte. IUBMB Life 63(10): 840-846.

2 Protocols published
Macrophage Polarization by Tumor-induced MDSCs Assay
Authors:  Felipe Vences-Catalán, Minu K. Srivastava and Shoshana Levy, date: 08/20/2016, view: 5300, Q&A: 0
Myeloid derived suppressor cells (MDSCs) are a subset of granulocytes (immature myeloid cells) that exploit a variety of mechanism to modulate the innate and adaptive immune system. MDSCs are present normally in the body, but their numbers increase ...
Adoptive Transfer of Tumor Expanded Regulatory T Cells (Tregs)
Authors:  Felipe Vences-Catalán and Shoshana Levy, date: 08/20/2016, view: 4336, Q&A: 0
Regulatory T cells (Tregs), a subset of CD4+CD25+ T cells, infiltrate tumors and suppress antitumor activity of effector T and NK cells. Depletion of Tregs by anti CD25+ antibodies has been shown to reduce tumor ...
您可以切换至中文站点,以获得适用于中国用户的内容 中文站点
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.